Sleep Pattern: Preventing Factors for Alzheimer Disease
Zhoobin Khorgami, Kiminobu Sugaya
Journal of Advances in Medicine and Medical Research · pp. 1–12 · Published 6 Jul 2015
10.9734/BJMMR/2015/19333Abstract
Alzheimer’s disease is investigated by scientists broadly. Although there is no definitive treatment, a better medical intervention can be assumed as a preventive medicine which postpones the onset of disease and delays its progression. Understanding that the sleep changes affect the brain which it will be stabilized later as a cardinal manifestation of disease leads us to review recent studies and theories. In this review, we show that the interruption of circadian rhythm along with disruption of immune and endocrine systems can cause neuronal physiology changes. These changes can enhance neuro inflammation pathology by the time through Aβ deposition forming plaques in the brain tissue. Besides higher level of Aβ in CSF, immune system dysfunction occurred by aging will change solubility of Aβ. Furthermore, the defect in insulin and subsequently decreases in insulin receptor impair glucose metabolism. The dysregulation of glucose metabolism expedites the degenerative pathway and contributes to other oxidative stresses in neurons. The cortex of brain gradually will be damaged extremely and the brain size will shrink intensely and atrophy. In summary, we found that improving of sleep quality can reduce the disease progression and delay its symptoms by having effects in neuropathology.
Cited by 2
Liya Tang, Wenping Liu, Yuhang Yang · Journal of Psychosomatic Research · 2020
Showing 1 of 2 known citations — external sources report more than can currently be individually listed.
Related research
- Regions and Sub-regions Dysfunctions in Alzheimer’s during Rest — shares topic coverage
- An Overview on the Aetiology and Treatment of Alzheimer's Disease — shares topic coverage
- Dementia Diagnosis and Alternate Treatment: A Recent Update on Treatment Options — shares topic coverage
- The Brain Cholinergic System in Neurodegenerative Diseases — shares topic coverage
- Synthesis and Development of BACE 1 Inhibitor for Alzheimer’s Diseases from Medicinal Plants — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
2
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.